Aqua Pharmaceuticals

Aqua Pharmaceuticals Holdings, Inc. was a specialty dermatology company focused on acquiring, developing and marketing under-promoted, branded, pharmaceutical products. Utilizing an 89-person sales force, the company marketed 5 NDA approved products throughout the U.S. with additional products in development. Aqua’s products included: Monodox capsules, an antibiotic used to treat acne; Cordran Cream and Lotion, indicated for the relief of inflammatory dermatoses; Xolegel, a Ketoconazole gel indicated to the topical treatment of seborrheic dermatitis; Fluoroplex Cream, indicated for the treatment of actinic keratoses; and Verdeso Foam, a low-potency corticosteroid indicated for the topical treatment of mild to moderate atopic dermatitis in patients 3 months of age and older. The company was headquartered in West Chester, Pennsylvania, and employed approximately 125 people.



LOCATION

West Chester, PA

SECTOR

Pharmaceuticals

TRANSACTION TYPE

Owner/Founder Partnership

INVESTMENT DATE

June 2010

EXIT DATE

December 2013

ACQUIRER

Almirall